Cargando…
Solid Tumor Differentiation Therapy – Is It Possible?
Genetic and epigenetic events within a cell which promote a block in normal development or differentiation coupled with unregulated proliferation are hallmarks of neoplastic transformation. Differentiation therapy involves the use of agents with the ability to induce differentiation in cells that ha...
Autores principales: | Dela Cruz, Filemon, Matushansky, Igor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388185/ https://www.ncbi.nlm.nih.gov/pubmed/22643847 |
Ejemplares similares
-
Terminal differentiation and loss of tumorigenicity of human cancers via pluripotency based reprogramming
por: Zhang, Xi, et al.
Publicado: (2012) -
The tumor vasculature an attractive CAR T cell target in solid tumors
por: Akbari, Parvin, et al.
Publicado: (2019) -
Cancer Stem Cells in Pediatric Sarcomas
por: Dela Cruz, Filemon S.
Publicado: (2013) -
Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs
por: Maeda, Hiroshi, et al.
Publicado: (2018) -
ctDNA: An emerging neoadjuvant biomarker in resectable solid tumors
por: Abbosh, Christopher, et al.
Publicado: (2021)